The head and neck squamous cell carcinoma market is experiencing significant growth, with its size projected to ...

The global recurrent head and neck cancer squamous cell carcinoma market is experiencing robust growth, projected to expand from $3.32 billion in 2025 to $3.55 billion in 2026 at ...

Cervical squamous cell carcinoma is one of the predominant histological subtypes of cervical cancer, with significant morbidity and mortality globally. Its management increasingly relies on the ...

Alpha Tau’s IMPACT trial is expected to enroll up to 30 patients across the U.S., Canada, and Israel, focusing on patients ...

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...